Loading
JB
Jinhe Biotechnology Co., Ltd.: what insiders have been doing
Jinhe Biotechnology Co., Ltd. is a Health Care company. Its directors and officers file their transactions with SSE / SZSE (CSRC). The past year has been quiet: not a single insider filing for Jinhe Biotechnology Co., Ltd. The previous disclosure was published on 19 August 2025.
Our records for Jinhe Biotechnology Co., Ltd. go back to 2022, with no purchases and 3 sales on the open market in total.
Elsewhere in the same sector, our signals recently picked up insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
Insider Decl.
3
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€5M
3 ops. · all time
Who traded when
BuySale内蒙古金河控股有限公司2 sales
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 17,568 of 23,476 companies
34.8
score / 100
Value40
Quality30
FCF yld3.4%
Earn yld0.6%
EV/EBITDA18.3x
ROE-0.5%
Gross mgn34%
Net mgn1.0%
Debt/EBITDA6.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CN¥5.20
Analyst consensus
Income statement
RevenueCN¥2.9B
Gross profitCN¥974.5M34% margin
EBITDACN¥364.2M13% margin
Net incomeCN¥27.6M0.7% margin
Valuation
PER (trailing)173.3x
P/Book1.7x
Beta0.33
Balance sheet & cash
Market capCN¥4.4B
Total debtCN¥2.3B
Free Cash FlowCN¥148.6M
Debt / Equity100%
Profitability & ownership
ROE-0.5%
ROA3.4%
% insiders34.5%
% institutions1.8%
Last declaration on 19 August 2025
Declarations3 total
462,400 shares8.9% of flowA股XSHESZSE:173000009367917800
5,065,000 shares91.1% of flowA股XSHESZSE:173000009488954000
3 of 3 declarations
About Jinhe Biotechnology Co., Ltd.
金河生物 is a company in the health and pharmaceutical sector, listed on the XSHE market. It focuses on the development and production of biological products.
